Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabine

被引：0
作者：
O. Juan
J. Vidal
R. Gisbert
J. Muñoz
S. Maciá
J. Gómez-Codina
机构：
[1] Hospital Universitari I Politècnic La Fe,Medical Oncology Department
[2] Hospital Arnau de Vilanova,Clinical Laboratory
[3] Hospital Dr Peset,Medical Oncology Department
[4] Hospital General de Elda,Medical Oncology Department
来源：
Clinical and Translational Oncology | 2014年 / 16卷
关键词：
Lung cancer; Circulating tumor cells; Prognosis; Non-small cell lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：637 / 643
页数：6
相关论文
共 50 条
[21]   Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy [J].
Coco, Simona ;
Alama, Angela ;
Vanni, Irene ;
Fontana, Vincenzo ;
Genova, Carlo ;
Dal Bello, Maria Giovanna ;
Truini, Anna ;
Rijavec, Erika ;
Biello, Federica ;
Sini, Claudio ;
Burrafato, Giovanni ;
Maggioni, Claudia ;
Barletta, Giulia ;
Grossi, Francesco .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (05)
[22]   Prognostic value of tumor mutations in radically treated locally advanced non-small cell lung cancer patients [J].
Boros, Angela ;
Lacroix, Ludovic ;
Lacas, Benjamin ;
Adam, Julien ;
Pignon, Jean-Pierre ;
Caramella, Caroline ;
Planchard, David ;
de Montpreville, Vincent ;
Deutsch, Eric ;
Levy, Antonin ;
Besse, Benjamin ;
Le Pechoux, Cecile .
ONCOTARGET, 2017, 8 (15) :25189-25199
[23]   Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer [J].
Naito, Tateaki ;
Tanaka, Fumihiro ;
Ono, Akira ;
Yoneda, Kazue ;
Takahashi, Toshiaki ;
Murakami, Haruyasu ;
Nakamura, Yukiko ;
Tsuya, Asuka ;
Kenmotsu, Hirotsugu ;
Shukuya, Takehito ;
Kaira, Kyoichi ;
Koh, Yasuhiro ;
Endo, Masahiro ;
Hasegawa, Seiki ;
Yamamoto, Nobuyuki .
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (03) :512-519
[24]   Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine [J].
Fischer, Juergen R. ;
Ohnmacht, Ute ;
Rieger, Norman ;
Zemaitis, Marius ;
Stoffregen, Clemens ;
Manegold, Christian ;
Lahm, Harald .
LUNG CANCER, 2007, 56 (01) :115-123
[25]   Clinical Significance of Circulating Tumor Cells and Free DNA in Non-small Cell Lung Cancer [J].
Isobe, Kazutoshi ;
Hata, Yoshinobu ;
Kobayashi, Kunihiko ;
Hirota, Nao ;
Sato, Keita ;
Sano, Go ;
Sugino, Keishi ;
Sakamoto, Susumu ;
Takai, Yujiro ;
Shibuya, Kazutoshi ;
Takagi, Keigo ;
Homma, Sakae .
ANTICANCER RESEARCH, 2012, 32 (08) :3339-3344
[26]   Prognostic significance of RelB overexpression in non-small cell lung cancer patients [J].
Qin, Hualong ;
Zhou, Jun ;
Zhou, Peng ;
Xu, Jingjing ;
Tang, Zaixiang ;
Ma, Haitao ;
Guo, Feng .
THORACIC CANCER, 2016, 7 (04) :415-421
[27]   A pharmacogenomic study of docetaxel and gemcitabine for the initial treatment of advanced non-small cell lung cancer [J].
Petty, W. Jeffrey ;
Knight, Sommer N. ;
Mosley, Libyadda ;
Lovato, James ;
Capellari, James ;
Tucker, Robert ;
Blackstock, A. William ;
Miller, Mark Steven ;
Miller, Antomus A. .
JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (03) :197-202
[28]   Influence of altering administration sequence of docetaxel, gemcitabine and cisplatin in patients with advanced non-small cell lung cancer [J].
Harita, S ;
Watanabe, Y ;
Kiura, K ;
Tabata, M ;
Takigawa, N ;
Kuyama, S ;
Kozuki, T ;
Kamei, H ;
Tada, A ;
Okimoto, N ;
Genba, K ;
Tada, S ;
Ueoka, H ;
Hiraki, S ;
Tanimoto, M .
ANTICANCER RESEARCH, 2006, 26 (2B) :1637-1641
[29]   Circulating DNA is a Useful Prognostic Factor in Patients with Advanced Non-small Cell Lung Cancer [J].
Sirera, Rafael ;
Bremnes, Roy M. ;
Cabrera, Andrea ;
Jantus-Lewintre, Eloisa ;
Sanmartin, Elena ;
Blasco, Ana ;
del Pozo, Nieves ;
Rosell, Rafael ;
Guijarro, Ricardo ;
Galbis, Jose ;
Javier Sanchez, Jose ;
Camps, Carlos .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (02) :286-290
[30]   Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel-gemcitabine chemotherapy [J].
Pallis, A. G. ;
Agelaki, S. ;
Kakolyris, S. ;
Kotsakis, A. ;
Kalykaki, A. ;
Vardakis, N. ;
Papakotoulas, P. ;
Agelidou, A. ;
Geroyianni, A. ;
Agelidou, M. ;
Hatzidaki, D. ;
Mavroudis, D. ;
Georgoulias, V. .
LUNG CANCER, 2008, 62 (03) :356-363
12345